Pharmabiz

Roche presents positive results from phase III IMAgINATION study of sefaxersen to treat primary IgA nephropathy at ASN Kidney Week 2026

Roche presents positive results from phase III IMAgINATION study of sefaxersen to treat primary IgA nephropathy at ASN Kidney Week 2026: Basel Monday, October 26, 2026, 13:00 Hrs ...
Pharmabiz

Cipla's InvaGen facility receives zero Form 483 observations from US FDA

Cipla's InvaGen facility receives zero Form 483 observations from US FDA: Our Bureau, Mumbai Monday, October 26, 2026, 13:15 Hrs [IST] Cipla Ltd announced that an inspection was c ...
Pharmabiz

Healthium Medtech repositions SIRONIX to target the broader orthopaedic care segment

Healthium Medtech repositions SIRONIX to target the broader orthopaedic care segment: Our Bureau, Bengaluru Monday, October 26, 2026, 13:30 Hrs [IST] Healthium Medtech, a global m ...
Opinion
PharmabizOpinion

India's diversity in genetics is a scientific advantage in clinical research: Dr Seema Pai

India's diversity in genetics is a scientific advantage in clinical research: Dr Seema Pai: Nandita Vijayasimha, Bengaluru Monday, October 26, 2026, 08:00 Hrs [IST] India’s dive ...
Pharmabiz

CDSCO acts on registration of one more Ethics Committee for violation of NDCT Rules

CDSCO acts on registration of one more Ethics Committee for violation of NDCT Rules: Gireesh Babu, New Delhi Monday, October 26, 2026, 08:00 Hrs [IST] The Central Drugs Standard C ...
Pharmabiz

Manufacturers & marketing cos face logistical bottleneck following NPPA’s order on TMR of cancer drugs

Manufacturers & marketing cos face logistical bottleneck following NPPA’s order on TMR of cancer drugs: Peethaambaran Kunnathoor, Chennai Monday, October 26, 2026, 08:00 Hrs [IS ...
Pharmabiz

Maharashtra leads bulk drug PLI scheme with 19,180 MT capacity across five projects

Maharashtra leads bulk drug PLI scheme with 19,180 MT capacity across five projects: Shardul Nautiyal, Mumbai Monday, October 26, 2026, 08:00 Hrs [IST] Maharashtra has recorded an ...
Pharmabiz

JAKs report 8% growth in sales during H1 FY26

The Jan Aushadhi Kendras (JAKs) under the flagship scheme of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) run by the Department of Pharmaceuticals (DoP), has reported a growth of 8% in sales ...
Pharmabiz

UK MHRA approves Janssen-Cilag’s Icotyde, a new oral treatment for moderate to severe plaque psoriasis

Cilag’s Icotyde, a new oral treatment for moderate to severe plaque psoriasis: United Kingdom Monday, October 26, 2026, 09:00 Hrs [IST] The Medicines an ...
Pharmabiz

Bayer announces darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence

Bayer announces darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence: Berlin Monday, Octob ...
Pharmabiz

Chinese NMPA approves Galderma’s Relfydess for frown lines

Zug, Switzerland Monday, October 26, 2026, 11:00 Hrs [IST] Galderma, a pure-play dermatology category leader, announc ...
Pharmabiz

PHOSSCON focuses on 60% childhood cancer survival target by 2030

PHOSSCON focuses on 60% childhood cancer survival target by 2030: Our Bureau, Mumbai Monday, October 26, 2026, 13:45 Hrs [IST] India’s goal of achieving a childhood cancer survi ...